AI assistant
Sending…
REVVITY, INC. — Director's Dealing 2014
May 1, 2014
30616_dirs_2014-05-01_b66ae712-27f1-4641-b019-c65399b00e1b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PERKINELMER INC (PKI)
CIK: 0000031791
Period of Report: 2014-04-29
Reporting Person: MICHAS ALEXIS P (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-04-29 | Common Stock | M | 7097 | $24.27 | Acquired | 103018 | Direct |
| 2014-04-29 | Common Stock | F | 4084 | $42.17 | Disposed | 98934 | Direct |
| 2014-04-29 | Common Stock | A | 2373 | $0.00 | Acquired | 101306 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-04-29 | NQ Stock Option | |||||||
| (right to buy) | $24.27 | M | 7097 | Disposed | 2014-05-01 | Common Stock (7097) | Direct | |
| 2014-04-29 | NQ Stock Option | |||||||
| (right to buy) | $42.085 | A | 4750 | Acquired | 2021-04-29 | Common Stock (4750) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 500 | Indirect |
Footnotes
F1: Includes shares related to dividends on shares in the Deferred Compensation Plan in the Reporting Person's account.
F2: This option became exercisable in three equal annual installments beginning on May 1, 2008, which was the first anniversary of the date on which the option was granted.
F3: This option vests in three equal annual installments beginning on the first anniversary of the date of grant, and has a 7 year exercise term.
More from REVVITY, INC.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 5
Regulatory Filings
2026
May 1
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Mar 27
Annual Report
2026
Mar 16
Proxy Solicitation & Information Statement
2026
Mar 16
Proxy Solicitation & Information Statement
2026
Mar 16
Regulatory Filings
2026
Mar 6
Director's Dealing
2026
Feb 26